No New Trial For Applied In Covidien IP Spat: Court

Law360, New York (February 25, 2009, 12:00 AM EST) -- A federal appeals court has denied Applied Medical Corp.'s bid for a new trial in the wake of a jury verdict that a Covidien AG subsidiary did not infringe the company's patent for trocar seal technology, affirming a lower court ruling.

In a ruling Tuesday, a three-judge panel of the U.S. Court of Appeals for the Federal Circuit rejected Applied's argument that the U.S. District Court for the Central District of California had wrongly quashed its request for disqualification of the verdict or a new trial...
To view the full article, register now.